Mi‐Hua Liu

1.2k total citations
31 papers, 1.0k citations indexed

About

Mi‐Hua Liu is a scholar working on Molecular Biology, Biochemistry and Surgery. According to data from OpenAlex, Mi‐Hua Liu has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Biochemistry and 6 papers in Surgery. Recurrent topics in Mi‐Hua Liu's work include Fibroblast Growth Factor Research (6 papers), Sirtuins and Resveratrol in Medicine (6 papers) and Sulfur Compounds in Biology (6 papers). Mi‐Hua Liu is often cited by papers focused on Fibroblast Growth Factor Research (6 papers), Sirtuins and Resveratrol in Medicine (6 papers) and Sulfur Compounds in Biology (6 papers). Mi‐Hua Liu collaborates with scholars based in China and United Kingdom. Mi‐Hua Liu's co-authors include Xiaolong Lin, Zhi‐Han Tang, Zhong Ren, Shun-Lin Qu, Xiao‐Long Lin, Lu-Shan Liu, Zhi-Sheng Jiang, Yuan Zhang, Xiaojuan Fan and Jun He and has published in prestigious journals such as Molecular and Cellular Biology, Clinica Chimica Acta and Atherosclerosis.

In The Last Decade

Mi‐Hua Liu

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mi‐Hua Liu China	20	403	188	179	140	140	31	1.0k
Sehwan Jang Puerto Rico	21	880 2.2×	432 2.3×	97 0.5×	120 0.9×	236 1.7×	30	1.6k
Md. Kaimul Ahsan United States	14	468 1.2×	196 1.0×	62 0.3×	49 0.3×	106 0.8×	21	841
Bingxian Xie United States	22	735 1.8×	213 1.1×	105 0.6×	78 0.6×	412 2.9×	45	1.4k
Renata B. Kostogrys Poland	18	246 0.6×	121 0.6×	99 0.6×	130 0.9×	199 1.4×	61	919
Lu-Shan Liu China	15	327 0.8×	99 0.5×	211 1.2×	97 0.7×	125 0.9×	26	854
Vikram Sharma United States	16	691 1.7×	242 1.3×	37 0.2×	209 1.5×	186 1.3×	65	1.5k
Xiaoyu Wang China	18	399 1.0×	413 2.2×	58 0.3×	79 0.6×	89 0.6×	61	969
Matthieu Ruiz Canada	18	398 1.0×	86 0.5×	45 0.3×	174 1.2×	197 1.4×	40	783
Emma Yu United Kingdom	8	674 1.7×	175 0.9×	51 0.3×	139 1.0×	255 1.8×	11	1.2k
Chia-Yao Shen Taiwan	19	387 1.0×	123 0.7×	30 0.2×	164 1.2×	124 0.9×	39	836

Countries citing papers authored by Mi‐Hua Liu

Since Specialization

Citations

This map shows the geographic impact of Mi‐Hua Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi‐Hua Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi‐Hua Liu more than expected).

Fields of papers citing papers by Mi‐Hua Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi‐Hua Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi‐Hua Liu. The network helps show where Mi‐Hua Liu may publish in the future.

Co-authorship network of co-authors of Mi‐Hua Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Mi‐Hua Liu. A scholar is included among the top collaborators of Mi‐Hua Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi‐Hua Liu. Mi‐Hua Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Mi‐Hua, et al.. (2024). Excess phosphate promotes SARS‑CoV‑2 N protein‑induced NLRP3 inflammasome activation via the SCAP‑SREBP2 signaling pathway. Molecular Medicine Reports. 29(3). 4 indexed citations

Liu, Mi‐Hua, et al.. (2023). SARS-CoV-2 nucleocapsid protein promotes TMAO-induced NLRP3 inflammasome activation by SCAP–SREBP signaling pathway. Tissue and Cell. 86. 102276–102276. 10 indexed citations

Li, Danyang, Mi‐Hua Liu, Zhe Li, et al.. (2021). Sterol-resistant SCAP Overexpression in Vascular Smooth Muscle Cells Accelerates Atherosclerosis by Increasing Local Vascular Inflammation through Activation of the NLRP3 Inflammasome in Mice. Aging and Disease. 12(3). 747–747. 20 indexed citations

Lin, Xiaolong, et al.. (2020). FGF21 induces autophagy‐mediated cholesterol efflux to inhibit atherogenesis via RACK1 up‐regulation. Journal of Cellular and Molecular Medicine. 24(9). 4992–5006. 37 indexed citations

Li, Zhe, Danyang Li, Li Wei, et al.. (2020). SCAP knockout in SM22α-Cre mice induces defective angiogenesis in the placental labyrinth. Biomedicine & Pharmacotherapy. 133. 111011–111011. 7 indexed citations

Hu, Huijun, et al.. (2018). FGF21 protects human umbilical vein endothelial cells against high glucose-induced apoptosis via PI3K/Akt/Fox3a signaling pathway. Journal of Diabetes and its Complications. 32(8). 729–736. 29 indexed citations

Lin, Xiaolong, et al.. (2018). Role of PCSK9 in lipid metabolism and atherosclerosis. Biomedicine & Pharmacotherapy. 104. 36–44. 50 indexed citations

Lin, Xiaolong, et al.. (2018). Molecular mechanisms of autophagy in cardiac ischemia/reperfusion injury (Review). Molecular Medicine Reports. 18(1). 675–683. 39 indexed citations

Lin, Xiaolong, Mi‐Hua Liu, Yuanbo Liu, et al.. (2017). Transforming growth factor β1 promotes migration and invasion in HepG2 cells: Epithelial‑to‑mesenchymal transition via JAK/STAT3 signaling. International Journal of Molecular Medicine. 41(1). 129–136. 25 indexed citations

10.

Lin, Xiaolong, Yuanbo Liu, Mi‐Hua Liu, et al.. (2017). Inhibition of Hydrogen Peroxide-Induced Human Umbilical Vein Endothelial Cells Aging by Allicin Depends on Sirtuin1 Activation. Medical Science Monitor. 23. 563–570. 25 indexed citations

11.

Liu, Mi‐Hua, Yuan Zhang, Jun He, et al.. (2016). Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway. International Journal of Molecular Medicine. 37(6). 1661–1668. 33 indexed citations

12.

He, Jun, Mi‐Hua Liu, Xinghui Liu, et al.. (2016). Insights into the pathogenesis of Mycoplasma pneumoniae. Molecular Medicine Reports. 14(5). 4030–4036. 95 indexed citations

13.

Liu, Mi‐Hua, et al.. (2015). Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway. Molecular Medicine Reports. 13(2). 1281–1286. 45 indexed citations

14.

Liu, Mi‐Hua, Yuan Zhang, Xiao‐Long Lin, et al.. (2015). Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting calreticulin expression in H9c2 cells. Molecular Medicine Reports. 12(4). 5197–5202. 5 indexed citations

15.

Lin, Xiao‐Long, et al.. (2015). Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells. Oncology Letters. 11(2). 1499–1505. 38 indexed citations

16.

Liu, Mi‐Hua, Xiao‐Long Lin, Jian Li, et al.. (2015). Resveratrol induces apoptosis through modulation of the Akt/FoxO3a/Bim pathway in HepG2 cells. Molecular Medicine Reports. 13(2). 1689–1694. 11 indexed citations

17.

Liu, Mi‐Hua, Yuan Zhang, Jun He, et al.. (2015). Upregulation of peroxiredoxin III in doxorubicin-induced cytotoxicity and the FoxO3a-dependent expression in H9c2 cardiac cells. Experimental and Therapeutic Medicine. 10(4). 1515–1520. 8 indexed citations

18.

Liu, Mi‐Hua, Cong Yuan, Jun He, et al.. (2014). Resveratrol Protects PC12 Cells from High Glucose-Induced Neurotoxicity Via PI3K/Akt/FoxO3a Pathway. Cellular and Molecular Neurobiology. 35(4). 513–522. 54 indexed citations

19.

Qu, Shun-Lin, Zhi‐Han Tang, Yuan Zhang, et al.. (2014). SIRT1 in cardiovascular aging. Clinica Chimica Acta. 437. 106–114. 65 indexed citations

20.

Liu, Mi‐Hua, Zhi‐Han Tang, Guohua Li, et al.. (2013). Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: Atherogenesis and angiogenesis. Atherosclerosis. 229(1). 10–17. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact